{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:07:30Z","timestamp":1794488850316,"version":"4.9.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Mater."],"DOI":"10.1038\/s41563-026-02724-1","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:03:14Z","timestamp":1790672594000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Controllable gene delivery via masked adeno-associated viral vectors"],"prefix":"10.1038","author":[{"given":"Zhiying","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6119-516X","authenticated-orcid":false,"given":"Jingjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingze","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2948-0077","authenticated-orcid":false,"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2947-4456","authenticated-orcid":false,"given":"Zhen","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5347-5892","authenticated-orcid":false,"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"2724_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41576-019-0205-4","volume":"21","author":"C Li","year":"2020","unstructured":"Li, C. & Samulski, R. J. Engineering adeno-associated virus vectors for gene therapy. Nat. Rev. Genet. 21, 255\u2013272 (2020).","journal-title":"Nat. Rev. Genet."},{"key":"2724_CR2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","volume":"9","author":"JH Wang","year":"2024","unstructured":"Wang, J. H., Gessler, D. J., Zhan, W., Gallagher, T. L. & Gao, G. Adeno-associated virus as a delivery vector for gene therapy of human diseases. Signal Transduct. Target. Ther. 9, 78 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2724_CR3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.cell.2020.03.023","volume":"181","author":"D Wang","year":"2020","unstructured":"Wang, D., Zhang, F. & Gao, G. CRISPR-based therapeutic genome editing: strategies and in vivo delivery by AAV vectors. Cell 181, 136\u2013150 (2020).","journal-title":"Cell"},{"key":"2724_CR4","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.neuron.2019.02.017","volume":"101","author":"E Hudry","year":"2019","unstructured":"Hudry, E. & Vandenberghe, L. H. Therapeutic AAV gene transfer to the nervous system: a clinical reality. Neuron 101, 839\u2013862 (2019).","journal-title":"Neuron"},{"key":"2724_CR5","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41592-023-01896-x","volume":"20","author":"J Zengel","year":"2023","unstructured":"Zengel, J. et al. Hardwiring tissue-specific AAV transduction in mice through engineered receptor expression. Nat. Methods 20, 1070\u20131081 (2023).","journal-title":"Nat. Methods"},{"key":"2724_CR6","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1016\/j.cell.2021.08.028","volume":"184","author":"M Tabebordbar","year":"2021","unstructured":"Tabebordbar, M. et al. Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species. Cell 184, 4919\u20134938 (2021).","journal-title":"Cell"},{"key":"2724_CR7","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/s41592-022-01547-7","volume":"19","author":"R Lin","year":"2022","unstructured":"Lin, R. et al. Directed evolution of adeno-associated virus for efficient gene delivery to microglia. Nat. Methods 19, 976\u2013985 (2022).","journal-title":"Nat. Methods"},{"key":"2724_CR8","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.adm8386","volume":"384","author":"Q Huang","year":"2024","unstructured":"Huang, Q. et al. An AAV capsid reprogrammed to bind human transferrin receptor mediates brain-wide gene delivery. Science 384, 1220\u20131227 (2024).","journal-title":"Science"},{"key":"2724_CR9","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/nn.4593","volume":"20","author":"KY Chan","year":"2017","unstructured":"Chan, K. Y. et al. Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nat. Neurosci. 20, 1172\u20131179 (2017).","journal-title":"Nat. Neurosci."},{"key":"2724_CR10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nbt.3440","volume":"34","author":"BE Deverman","year":"2016","unstructured":"Deverman, B. E. et al. Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain. Nat. Biotechnol. 34, 204\u2013209 (2016).","journal-title":"Nat. Biotechnol."},{"key":"2724_CR11","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3390\/v16030442","volume":"16","author":"E Lopez-Gordo","year":"2024","unstructured":"Lopez-Gordo, E., Chamberlain, K., Riyad, J. M., Kohlbrenner, E. & Weber, T. Natural adeno-associated virus serotypes and engineered adeno-associated virus capsid variants: tropism differences and mechanistic insights. Viruses 16, 442 (2024).","journal-title":"Viruses"},{"key":"2724_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17047-1","volume":"11","author":"HL Hsu","year":"2020","unstructured":"Hsu, H. L. et al. Structural characterization of a novel human adeno-associated virus capsid with neurotropic properties. Nat. Commun. 11, 3279 (2020).","journal-title":"Nat. Commun."},{"key":"2724_CR13","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/s41551-022-00938-7","volume":"6","author":"YZ Yao","year":"2022","unstructured":"Yao, Y. Z. et al. Variants of the adeno-associated virus serotype 9 with enhanced penetration of the blood\u2013brain barrier in rodents and primates. Nat. Biomed. Eng. 6, 1257\u20131271 (2022).","journal-title":"Nat. Biomed. Eng."},{"key":"2724_CR14","doi-asserted-by":"publisher","first-page":"101378","DOI":"10.1016\/j.omtm.2024.101378","volume":"32","author":"O Olarewaju","year":"2024","unstructured":"Olarewaju, O. et al. \u03b1FAP-specific nanobodies mediate a highly precise retargeting of modified AAV2 capsids thereby enabling specific transduction of tumor tissues. Mol. Ther. Methods Clin. Dev. 32, 101378 (2024).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"2724_CR15","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.actbio.2024.07.023","volume":"187","author":"YJ Zhang","year":"2024","unstructured":"Zhang, Y. J. et al. Site-specific tethering nanobodies on recombinant adeno-associated virus vectors for retargeted gene therapy. Acta Biomater. 187, 304\u2013315 (2024).","journal-title":"Acta Biomater."},{"key":"2724_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.omtm.2019.09.003","volume":"15","author":"AM Eichhoff","year":"2019","unstructured":"Eichhoff, A. M. et al. Nanobody-enhanced targeting of AAV gene therapy vectors. Mol. Ther. Methods Clin. Dev. 15, 211\u2013220 (2019).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"2724_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.omtn.2023.01.007","volume":"31","author":"F Puzzo","year":"2023","unstructured":"Puzzo, F. et al. Aptamer-programmable adeno-associated viral vectors as a novel platform for cell-specific gene transfer. Mol. Ther. Nucleic Acids 31, 383\u2013397 (2023).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2724_CR18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.biomaterials.2015.11.066","volume":"80","author":"CL Zhang","year":"2016","unstructured":"Zhang, C. L. et al. Development of next generation adeno-associated viral vectors capable of selective tropism and efficient gene delivery. Biomaterials 80, 134\u2013145 (2016).","journal-title":"Biomaterials"},{"key":"2724_CR19","doi-asserted-by":"publisher","first-page":"10645","DOI":"10.1002\/anie.201604067","volume":"55","author":"RE Kelemen","year":"2016","unstructured":"Kelemen, R. E. et al. A precise chemical strategy to alter the receptor specificity of the adeno-associated virus. Angew. Chem. Int. Ed. 55, 10645\u201310649 (2016).","journal-title":"Angew. Chem. Int. Ed."},{"key":"2724_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nbt.4034","volume":"36","author":"R Schubert","year":"2018","unstructured":"Schubert, R. et al. Virus stamping for targeted single-cell infection in vitro and in vivo. Nat. Biotechnol. 36, 81\u201388 (2018).","journal-title":"Nat. Biotechnol."},{"key":"2724_CR21","doi-asserted-by":"publisher","first-page":"20507","DOI":"10.1021\/jacs.2c09484","volume":"144","author":"Z Yuan","year":"2022","unstructured":"Yuan, Z. et al. Mitigating the immunogenicity of AAV-mediated gene therapy with an immunosuppressive phosphoserine-containing zwitterionic peptide. J. Am. Chem. Soc. 144, 20507\u201320513 (2022).","journal-title":"J. Am. Chem. Soc."},{"key":"2724_CR22","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.1002\/anie.201201495","volume":"51","author":"E Kim","year":"2012","unstructured":"Kim, E. et al. Drawing sticky adeno-associated viruses on surfaces for spatially patterned gene expression. Angew. Chem. Int. Ed. 51, 5598\u20135601 (2012).","journal-title":"Angew. Chem. Int. Ed."},{"key":"2724_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201906508","volume":"32","author":"H Madry","year":"2020","unstructured":"Madry, H. et al. Thermosensitive hydrogel based on PEO-PPO-PEO poloxamers for a controlled in situ release of recombinant adeno-associated viral vectors for effective gene therapy of cartilage defects. Adv. Mater. 32, e1906508 (2020).","journal-title":"Adv. Mater."},{"key":"2724_CR24","doi-asserted-by":"publisher","first-page":"6113","DOI":"10.1039\/D0BM01367F","volume":"8","author":"K Kaygisiz","year":"2020","unstructured":"Kaygisiz, K. & Synatschke, C. V. Materials promoting viral gene delivery. Biomater. Sci. 8, 6113\u20136156 (2020).","journal-title":"Biomater. Sci."},{"key":"2724_CR25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrd2468","volume":"7","author":"J Rautio","year":"2008","unstructured":"Rautio, J. et al. Prodrugs: design and clinical applications. Nat. Rev. Drug Discov. 7, 255\u2013270 (2008).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2724_CR26","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/s41587-019-0135-x","volume":"37","author":"VH Trang","year":"2019","unstructured":"Trang, V. H. et al. A coiled-coil masking domain for selective activation of therapeutic antibodies. Nat. Biotechnol. 37, 761\u2013765 (2019).","journal-title":"Nat. Biotechnol."},{"key":"2724_CR27","doi-asserted-by":"publisher","first-page":"207ra144","DOI":"10.1126\/scitranslmed.3006682","volume":"5","author":"LR Desnoyers","year":"2013","unstructured":"Desnoyers, L. R. et al. Tumor-specific activation of an EGFR-targeting probody enhances therapeutic index. Sci. Transl. Med. 5, 207ra144 (2013).","journal-title":"Sci. Transl. Med."},{"key":"2724_CR28","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/s41551-022-00888-0","volume":"6","author":"A Mansurov","year":"2022","unstructured":"Mansurov, A. et al. Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker. Nat. Biomed. Eng. 6, 819\u2013829 (2022).","journal-title":"Nat. Biomed. Eng."},{"key":"2724_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abi6899","volume":"7","author":"DY Xue","year":"2022","unstructured":"Xue, D. Y. et al. A tumor-specific pro-IL-12 activates preexisting cytotoxic T cells to control established tumors. Sci. Immunol. 7, eabi6899 (2022).","journal-title":"Sci. Immunol."},{"key":"2724_CR30","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3390\/ph18020210","volume":"18","author":"D Boreski","year":"2025","unstructured":"Boreski, D. et al. Current trends in clinical trials of prodrugs. Pharmaceuticals 18, 210 (2025).","journal-title":"Pharmaceuticals"},{"key":"2724_CR31","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.1158\/1078-0432.CCR-21-0194","volume":"27","author":"M Johnson","year":"2021","unstructured":"Johnson, M. et al. Phase I, first-in-human study of the probody therapeutic CX-2029 in adults with advanced solid tumor malignancies. Clin. Cancer Res. 27, 4521\u20134530 (2021).","journal-title":"Clin. Cancer Res."},{"key":"2724_CR32","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ymthe.2019.01.015","volume":"27","author":"CM Guenther","year":"2019","unstructured":"Guenther, C. M. et al. Protease-activatable adeno-associated virus vector for gene delivery to damaged heart tissue. Mol. Ther. 27, 611\u2013622 (2019).","journal-title":"Mol. Ther."},{"key":"2724_CR33","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41434-021-00255-9","volume":"29","author":"SS Butler","year":"2022","unstructured":"Butler, S. S. et al. Membrane-bound MMP-14 protease-activatable adeno-associated viral vectors for gene delivery to pancreatic tumors. Gene Ther 29, 138\u2013146 (2022).","journal-title":"Gene Ther"},{"key":"2724_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abf0797","volume":"7","author":"M H\u00f6rner","year":"2021","unstructured":"H\u00f6rner, M. et al. Spatiotemporally confined red light-controlled gene delivery at single-cell resolution using adeno-associated viral vectors. Sci. Adv. 7, eabf0797 (2021).","journal-title":"Sci. Adv."},{"key":"2724_CR35","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1021\/acsnano.5b05558","volume":"10","author":"EJ Gomez","year":"2016","unstructured":"Gomez, E. J. et al. Light-activated nuclear translocation of adeno-associated virus nanoparticles using phytochrome B for enhanced, tunable, and spatially programmable gene delivery. ACS Nano 10, 225\u2013237 (2016).","journal-title":"ACS Nano"},{"key":"2724_CR36","doi-asserted-by":"publisher","first-page":"4234","DOI":"10.1002\/anie.201700683","volume":"56","author":"SB Erickson","year":"2017","unstructured":"Erickson, S. B. et al. Precise photoremovable perturbation of a virus\u2013host interaction. Angew. Chem. Int. Ed. 56, 4234\u20134237 (2017).","journal-title":"Angew. Chem. Int. Ed."},{"key":"2724_CR37","doi-asserted-by":"publisher","first-page":"5178","DOI":"10.1128\/JVI.02721-07","volume":"82","author":"N DiPrimio","year":"2008","unstructured":"DiPrimio, N. et al. Surface loop dynamics in adeno-associated virus capsid assembly. J. Virol. 82, 5178\u20135189 (2008).","journal-title":"J. Virol."},{"key":"2724_CR38","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1021\/acssynbio.5c00910","volume":"15","author":"N Graham","year":"2026","unstructured":"Graham, N. et al. Receptor-guided AAV tropism engineering via MATCH. ACS Synth. Biol. 15, 2302\u20132313 (2026).","journal-title":"ACS Synth. Biol."},{"key":"2724_CR39","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1039\/C9SC04189C","volume":"11","author":"M Mathieu","year":"2020","unstructured":"Mathieu, M. et al. Chemical modification of the adeno-associated virus capsid to improve gene delivery. Chem. Sci. 11, 1122\u20131131 (2020).","journal-title":"Chem. Sci."},{"key":"2724_CR40","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1089\/hum.2021.124","volume":"32","author":"AK Lam","year":"2021","unstructured":"Lam, A. K., Frabutt, D., Li, L. & Xiao, W. Chemical modifications of the capsid for redirecting and improving the efficacy of adeno-associated virus vectors. Hum. Gene Ther. 32, 1433\u20131438 (2021).","journal-title":"Hum. Gene Ther."},{"key":"2724_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/bit.20562","volume":"92","author":"GK Lee","year":"2005","unstructured":"Lee, G. K., Maheshri, N., Kaspar, B. & Schaffer, D. V. PEG conjugation moderately protects adeno-associated viral vectors against antibody neutralization. Biotechnol. Bioeng. 92, 24\u201334 (2005).","journal-title":"Biotechnol. Bioeng."},{"key":"2724_CR42","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.str.2012.05.004","volume":"20","author":"TF Lerch","year":"2012","unstructured":"Lerch, T. F. & Chapman, M. S. Structure of AAV-DJ, a retargeted gene therapy vector: cryo-electron microscopy at 4.5\u2009\u00c5 resolution. Structure 20, 1310\u20131320 (2012).","journal-title":"Structure"},{"key":"2724_CR43","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature16465","volume":"530","author":"S Pillay","year":"2016","unstructured":"Pillay, S. et al. An essential receptor for adeno-associated virus infection. Nature 530, 108\u2013112 (2016).","journal-title":"Nature"},{"key":"2724_CR44","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1111\/febs.15227","volume":"287","author":"M Poreba","year":"2020","unstructured":"Poreba, M. Protease-activated prodrugs: strategies, challenges, and future directions. FEBS J. 287, 1936\u20131969 (2020).","journal-title":"FEBS J."},{"key":"2724_CR45","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41575-022-00729-0","volume":"20","author":"N Zabaleta","year":"2023","unstructured":"Zabaleta, N., Unzu, C., Weber, N. D. & Gonzalez-Aseguinolaza, G. Gene therapy for liver diseases\u2014progress and challenges. Nat. Rev. Gastroenterol. Hepatol. 20, 288\u2013305 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2724_CR46","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3324\/haematol.2008.001867","volume":"94","author":"AJ Ramsay","year":"2009","unstructured":"Ramsay, A. J., Hooper, J. D., Folgueras, A. R., Velasco, G. & Lopez-Otin, C. Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis. Haematologica 94, 840\u2013849 (2009).","journal-title":"Haematologica"},{"key":"2724_CR47","doi-asserted-by":"publisher","first-page":"e105984","DOI":"10.1371\/journal.pone.0105984","volume":"9","author":"O Barr\u00e9","year":"2014","unstructured":"Barr\u00e9, O. et al. Cleavage specificity analysis of six type II transmembrane serine proteases (TTSPs) using PICS with proteome-derived peptide libraries. PLoS One 9, e105984 (2014).","journal-title":"PLoS One"},{"key":"2724_CR48","doi-asserted-by":"crossref","unstructured":"B\u00e9liveau, F., Desilets, A. & Leduc, R. Probing the substrate specificities of matriptase, matriptase-2, hepsin and DESC1 with internally quenched fluorescent peptides. FEBS J. 276, 2213\u20132226 (2009).","DOI":"10.1111\/j.1742-4658.2009.06950.x"},{"key":"2724_CR49","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1126\/science.aaq1144","volume":"359","author":"S Chen","year":"2018","unstructured":"Chen, S. et al. Near-infrared deep brain stimulation via upconversion nanoparticle-mediated optogenetics. Science 359, 679\u2013684 (2018).","journal-title":"Science"},{"key":"2724_CR50","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41586-019-1188-1","volume":"569","author":"J Wang","year":"2019","unstructured":"Wang, J. et al. Time-resolved protein activation by proximal decaging in living systems. Nature 569, 509\u2013513 (2019).","journal-title":"Nature"},{"key":"2724_CR51","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz659","volume":"47","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. Generation of a caged lentiviral vector through an unnatural amino acid for photo-switchable transduction. Nucleic Acids Res. 47, e114 (2019).","journal-title":"Nucleic Acids Res."},{"key":"2724_CR52","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1021\/acs.accounts.8b00384","volume":"51","author":"AP Gorka","year":"2018","unstructured":"Gorka, A. P., Nani, R. R. & Schnermann, M. J. Harnessing cyanine reactivity for optical imaging and drug delivery. Acc. Chem. Res. 51, 3226\u20133235 (2018).","journal-title":"Acc. Chem. Res."},{"key":"2724_CR53","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41596-018-0097-3","volume":"14","author":"RC Challis","year":"2019","unstructured":"Challis, R. C. et al. Systemic AAV vectors for widespread and targeted gene delivery in rodents. Nat. Protoc. 14, 379\u2013414 (2019).","journal-title":"Nat. Protoc."},{"key":"2724_CR54","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.omtm.2022.05.009","volume":"26","author":"GX Xu","year":"2022","unstructured":"Xu, G. X. et al. Structural basis for the neurotropic AAV9 and the engineered AAVPHP.eB recognition with cellular receptors. Mol. Ther. Methods Clin. Dev. 26, 52\u201360 (2022).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"2724_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0225206","volume":"14","author":"Q Huang","year":"2019","unstructured":"Huang, Q. et al. Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids. PLoS One 14, e0225206 (2019).","journal-title":"PLoS One"},{"key":"2724_CR56","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41580-022-00456-z","volume":"23","author":"H Sies","year":"2022","unstructured":"Sies, H. et al. Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology. Nat. Rev. Mol. Cell Biol. 23, 499\u2013515 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2724_CR57","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41578-022-00426-z","volume":"7","author":"ZX Tu","year":"2022","unstructured":"Tu, Z. X. et al. Design of therapeutic biomaterials to control inflammation. Nat. Rev. Mater. 7, 557\u2013574 (2022).","journal-title":"Nat. Rev. Mater."},{"key":"2724_CR58","doi-asserted-by":"publisher","first-page":"15758","DOI":"10.1021\/ja303372u","volume":"134","author":"CD Lux","year":"2012","unstructured":"Lux, C. D. et al. Biocompatible polymeric nanoparticles degrade and release cargo in response to biologically relevant levels of hydrogen peroxide. J. Am. Chem. Soc. 134, 15758\u201315764 (2012).","journal-title":"J. Am. Chem. Soc."},{"key":"2724_CR59","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/112_2018_10","volume":"175","author":"T Luangmonkong","year":"2018","unstructured":"Luangmonkong, T. et al. Targeting oxidative stress for the treatment of liver fibrosis. Rev. Physiol. Biochem. Pharmacol. 175, 71\u2013102 (2018).","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"2724_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57382-9","volume":"16","author":"R Ferriero","year":"2025","unstructured":"Ferriero, R. et al. Impact of liver fibrosis on AAV-mediated gene transfer to mouse hepatocytes. Nat. Commun. 16, 2118 (2025).","journal-title":"Nat. Commun."},{"key":"2724_CR61","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.freeradbiomed.2018.01.024","volume":"117","author":"S Cadenas","year":"2018","unstructured":"Cadenas, S. ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection. Free Radic. Biol. Med. 117, 76\u201389 (2018).","journal-title":"Free Radic. Biol. Med."},{"key":"2724_CR62","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41573-021-00355-6","volume":"21","author":"A Coll\u00e9n","year":"2022","unstructured":"Coll\u00e9n, A. et al. VEGFA mRNA for regenerative treatment of heart failure. Nat. Rev. Drug Discov. 21, 79\u201380 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2724_CR63","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.ymthe.2022.11.017","volume":"31","author":"V Anttila","year":"2023","unstructured":"Anttila, V. et al. Direct intramyocardial injection of VEGF mRNA in patients undergoing coronary artery bypass grafting. Mol. Ther. 31, 866\u2013874 (2023).","journal-title":"Mol. Ther."},{"key":"2724_CR64","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13046-020-01709-5","volume":"39","author":"X Jiang","year":"2020","unstructured":"Jiang, X. et al. The role of microenvironment in tumor angiogenesis. J. Exp. Clin. Cancer Res. 39, 204 (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2724_CR65","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.7150\/thno.89380","volume":"14","author":"BP Dhungel","year":"2024","unstructured":"Dhungel, B. P. et al. Understanding AAV vector immunogenicity: from particle to patient. Theranostics 14, 1260\u20131288 (2024).","journal-title":"Theranostics"},{"key":"2724_CR66","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1038\/s41563-025-02240-8","volume":"24","author":"SJ Luozhong","year":"2025","unstructured":"Luozhong, S. J. et al. Poly(carboxybetaine) lipids enhance mRNA therapeutics efficacy and reduce their immunogenicity. Nat. Mater. 24, 1852\u20131861 (2025).","journal-title":"Nat. Mater."},{"key":"2724_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36658-y","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Noncanonical amino acids as doubly bio-orthogonal handles for one-pot preparation of protein multiconjugates. Nat. Commun. 14, 974 (2023).","journal-title":"Nat. Commun."},{"key":"2724_CR68","doi-asserted-by":"publisher","first-page":"7245","DOI":"10.1021\/jacs.9b11520","volume":"142","author":"HS Jang","year":"2020","unstructured":"Jang, H. S., Jana, S., Blizzard, R. J., Meeuwsen, J. C. & Mehl, R. A. Access to faster eukaryotic cell labeling with encoded tetrazine amino acids. J. Am. Chem. Soc. 142, 7245\u20137249 (2020).","journal-title":"J. Am. Chem. Soc."},{"key":"2724_CR69","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1016\/j.ymthe.2025.03.037","volume":"33","author":"AM Keeler","year":"2025","unstructured":"Keeler, A. M. et al. The curious case of AAV immunology. Mol. Ther. 33, 1946\u20131965 (2025).","journal-title":"Mol. Ther."},{"key":"2724_CR70","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/s41587-023-01974-7","volume":"42","author":"AG Jenny","year":"2024","unstructured":"Jenny, A. G. et al. Integrated vector genomes may contribute to long-term expression in primate liver after AAV administration. Nat. Biotechnol. 42, 1232\u20131242 (2024).","journal-title":"Nat. Biotechnol."},{"key":"2724_CR71","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41586-023-05870-7","volume":"616","author":"J Kreitz","year":"2023","unstructured":"Kreitz, J. et al. Programmable protein delivery with a bacterial contractile injection system. Nature 616, 357\u2013364 (2023).","journal-title":"Nature"},{"key":"2724_CR72","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","volume":"185","author":"S Banskota","year":"2022","unstructured":"Banskota, S. et al. Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins. Cell 185, 250\u2013265.e16 (2022).","journal-title":"Cell"},{"key":"2724_CR73","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41565-024-01851-7","volume":"20","author":"S Ling","year":"2025","unstructured":"Ling, S. et al. Customizable virus-like particles deliver CRISPR-Cas9 ribonucleoprotein for effective ocular neovascular and Huntington\u2019s disease gene therapy. Nat. Nanotechnol. 20, 543\u2013553 (2025).","journal-title":"Nat. Nanotechnol."},{"key":"2724_CR74","doi-asserted-by":"publisher","first-page":"5357","DOI":"10.1016\/j.cell.2024.07.023","volume":"187","author":"DW Brown","year":"2024","unstructured":"Brown, D. W. et al. Safe and effective in vivo delivery of DNA and RNA using proteolipid vehicles. Cell 187, 5357\u20135375.e24 (2024).","journal-title":"Cell"}],"container-title":["Nature Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41563-026-02724-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41563-026-02724-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41563-026-02724-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:03:23Z","timestamp":1790672603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41563-026-02724-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":74,"alternative-id":["2724"],"URL":"https:\/\/doi.org\/10.1038\/s41563-026-02724-1","relation":{},"ISSN":["1476-1122","1476-4660"],"issn-type":[{"value":"1476-1122","type":"print"},{"value":"1476-4660","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.L., Z.Z. and L.C. are named inventors on a patent application (CN 202611031823.X), filed by Peking University, related to the masked AAV platform described in this work. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}